Machine Learning Prediction and Reducing Overdoses With Electronic Health Record Nudges (mPROVEN) in the Primary Care Setting: Protocol for a Cluster Randomized Controlled Trial
JMIR Research Protocols · 2026-05-04 · 15 · e94007
DOI: 10.2196/94007 ↗At a glance
Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2026-05-04. Written by Walid F Gellad and 15 co-authors. Institution: Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, United States. Major MEDLINE topics: Drug Overdose, Electronic Health Records, Machine Learning. 47 references. The full text is freely available in PubMed Central. Funded by: NIDA NIH HHS.
Abstract (original language)
Background
Opioid overdose remains a leading cause of preventable death in the United States. Existing approaches to identify individuals at elevated risk rely on imprecise rule-based criteria that misclassify patients’ risk of this serious health outcome. Machine learning (ML) algorithms can help improve prediction performance and can be combined with electronic health record (EHR) interventions to reduce overdose risk.
Objective
The Machine Learning Prediction and Reducing Overdoses With EHR Nudges (mPROVEN) clinical trial integrates a validated ML overdose risk model with behavioral economics–informed EHR nudges to test whether the combination improves evidence-based prescribing behaviors associated with lower overdose risk and, ultimately, reduces overdose among elevated-risk patients. Methods mPROVEN is a pragmatic cluster randomized controlled trial conducted in primary care practices within a large multistate integrated health system. Eligible patients are adults (≥18 years) identified by the ML algorithm as having elevated overdose risk and seen at a primary care visit during the study period. Primary care practices serve as the unit of randomization and will be randomized into three arms: (1) usual care; (2) elevated risk flag only, where clinicians see a noninterruptive EHR flag indicating elevated overdose risk; and (3) elevated risk flag + nudges, in which active choice and accountable justification alerts are embedded within the EHR in addition to the elevated risk flag. The trial will enroll a target cohort of 800 patients for the primary analysis. The intervention period is 4 months (or until the study ends, whichever occurs later). The primary outcome is a 3‑point composite measure of safer opioid prescribing at 4 months, awarding 1 point each for active naloxone prescription, average opioid dosage of 50 morphine milligram equivalents per day or less, and absence of opioid-benzodiazepine overlap. Secondary outcomes include the composite outcome at 6 months, individual score components, and all-cause and overdose-specific emergency department or inpatient visits. Outcomes will be compared across study arms using an intention‑to‑treat approach with linear mixed‑effects models accounting for clinic-level clustering.
Results
Funded by the National Institutes of Health, in June 2022, enrollment began on March 10, 2025. Enrollment for the primary analysis cohort (n=798) was completed in May 2025 with additional participants enrolled for secondary analyses through December 2025 (n=1662). Primary cohort analyses began in January 2026, and results are expected by mid-2027.
Conclusions
The mPROVEN study is among the first pragmatic randomized controlled trials to integrate ML‑based opioid overdose risk prediction with behavioral nudges within a large health system EHR. By combining advances in data science and behavioral economics, the study aims to reduce opioid overdose risk in primary care using a scalable and low-touch intervention to address a high-priority public health issue. Trial Registration ClinicalTrials.gov NCT06806163; https://clinicaltrials.gov/study/NCT06806163 International Registered Report Identifier (IRRID) DERR1-10.2196/94007
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
- Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, PA, United States.
- VA Pittsburgh Healthcare System, Pittsburgh, PA, United States.
- Center for Biostatistics and Qualitative Methodology, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, United States.
- Applied Decision Science, Cincinnati, OH, United States.
ORCID profiles: Walid F Gellad, Yi-Fan Chen, Tae Woo Park, Qingnan Yang, Jonathan D Arnold, Courtney C Kuza, Stephanie N Fedro-Byrom, Julie Diiulio, Laura G Militello, Michelle Whitlock, Eugene M Sadhu, Shyam Visweswaran, Michael J Fine, Kaleab Z Abebe, Katie J Suda, Wei-Hsuan Lo-Ciganic
Funding
- NIDA NIH HHS
Cite
APA
Gellad, W. F., Chen, Y. F., Park, T. W., Yang, Q., Arnold, J. D., Kuza, C. C., Fedro-Byrom, S. N., Diiulio, J., Militello, L. G., Whitlock, M., Sadhu, E. M., Visweswaran, S., Fine, M. J., Abebe, K. Z., Suda, K. J., & Lo-Ciganic, W. H. (2026). Machine Learning Prediction and Reducing Overdoses With Electronic Health Record Nudges (mPROVEN) in the Primary Care Setting: Protocol for a Cluster Randomized Controlled Trial. JMIR Research Protocols, 15, e94007. https://doi.org/10.2196/94007
Vancouver
Gellad WF, Chen YF, Park TW, Yang Q, Arnold JD, Kuza CC, et al. Machine Learning Prediction and Reducing Overdoses With Electronic Health Record Nudges (mPROVEN) in the Primary Care Setting: Protocol for a Cluster Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e94007. doi:10.2196/94007
BibTeX
@article{Gellad2026,
author = {Gellad, Walid F and Chen, Yi-Fan and Park, Tae Woo and Yang, Qingnan and Arnold, Jonathan D and Kuza, Courtney C and Fedro-Byrom, Stephanie N and Diiulio, Julie and Militello, Laura G and Whitlock, Michelle and Sadhu, Eugene M and Visweswaran, Shyam and Fine, Michael J and Abebe, Kaleab Z and Suda, Katie J and Lo-Ciganic, Wei-Hsuan},
title = {Machine Learning Prediction and Reducing Overdoses With Electronic Health Record Nudges (mPROVEN) in the Primary Care Setting: Protocol for a Cluster Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2026},
volume = {15},
pages = {e94007},
doi = {10.2196/94007}
}
EUVIMED